Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDA | P32320 | 9/20 | 0.54 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.42 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.42 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.42 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | PYGM | P11217 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29047907 | 0.86 | CDA (0.55) | CDASLC28A1SLC28A2SLC29A1SLC28A3 | |
| SCHEMBL10859054 | 0.83 | CDA (0.52) | CDASLC28A1SLC28A2SLC29A1SLC28A3 | |
| SCHEMBL29180738 | 0.81 | CDA (0.54) | CDASLC28A1SLC28A2SLC29A1SLC28A3 | |
| SCHEMBL7452161 | 0.80 | CDA (0.49) | CDASLC28A1SLC28A2SLC29A1SLC28A3 | |
| SCHEMBL7452167 | 0.80 | CDA (0.49) | CDASLC28A1SLC28A2SLC29A1SLC28A3 | |
| SCHEMBL15010376 | 0.78 | CDA (0.54) | CDASLC28A1SLC28A2SLC29A1SLC28A3 | |
| SCHEMBL10709774 | 0.77 | P2RY2 (0.56) | — | |
| SCHEMBL6026652 | 0.77 | TK1 (0.43) | — | |
| SCHEMBL5982761 | 0.77 | TK1 (0.43) | — | |
| SCHEMBL15010708 | 0.76 | CDA (0.52) | CDASLC28A1SLC28A2SLC29A1SLC28A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023217209-A1 | DOUBLE-STRANDED RNA MOLECULE AND PHARMACEUTICAL USE THEREOF | 澳门科技大学 | 2023-11-16 | — | — | WO | claimed |
| CN-114875027-A | Double-stranded RNA molecule and medical application thereof | 澳门科技大学 | 2022-08-09 | — | — | CN | claimed |
| CN-117642421-A | Engineered immune cells specifically targeting mesothelin and uses thereof | 武田药品工业株式会社 | 2024-03-01 | — | — | CN | disclosed |
| CN-115927301-B | RNAi-based spodoptera frugiperda control method | 西北农林科技大学 | 2024-02-23 | — | — | CN | disclosed |
| WO-2024008192-A2 | MODIFIED SELF-REPLICATING MRNA | 嘉晨西海(杭州)生物技术有限公司 | 2024-01-11 | — | — | WO | disclosed |
| CN-117377756-A | Engineered immune cell therapies | 菲克特生物科学股份有限公司 | 2024-01-09 | — | — | CN | disclosed |
| WO-2023217209-A1 | DOUBLE-STRANDED RNA MOLECULE AND PHARMACEUTICAL USE THEREOF | 澳门科技大学 | 2023-11-16 | — | — | WO | disclosed |
| CN-115927301-A | Rnai-based Spodoptera frugiperda control method | 西北农林科技大学 | 2023-04-07 | — | — | CN | disclosed |
| CN-115701285-A | Mesenchymal stem cell therapy | 菲克特生物科学股份有限公司 | 2023-02-07 | — | — | CN | disclosed |
| CN-115052986-A | Compositions comprising nucleases and uses thereof | 阿伯生物技术公司 | 2022-09-13 | — | — | CN | disclosed |
| CN-114875027-A | Double-stranded RNA molecule and medical application thereof | 澳门科技大学 | 2022-08-09 | — | — | CN | disclosed |
| CN-112805386-A | Plasmid containing a sequence encoding mRNA having a segmented poly (A) tail | 埃泽瑞斯公司 | 2021-05-14 | — | — | CN | disclosed |
| CN-111819185-A | Compositions comprising cyclic polyribonucleotides and uses thereof | 旗舰创业创新第六有限责任公司 | 2020-10-23 | — | — | CN | disclosed |
| CN-111744019-A | Mannose-based mRNA (messenger ribonucleic acid) targeted delivery system and application thereof | 深圳市瑞吉生物科技有限公司 | 2020-10-09 | — | — | CN | disclosed |
| CN-110914433-A | Nucleic acids encoding CRISPR-associated proteins and uses thereof | 库尔维科公司 | 2020-03-24 | — | — | CN | disclosed |
| EP-2833921-A2 | MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF SECRETED PROTEINS | Moderna Therapeutics, Inc. (US) | 2015-02-11 | — | — | EP | disclosed |
| WO-2013151668-A2 | MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF SECRETED PROTEINS | modeRNA Therapeutics (US) | 2013-10-10 | — | — | WO | disclosed |
| US-20020182626-A1 | Episomal non-transforming nucleic acid elements in functional genomic and antigenic applications | LARGE SCALE BIOLOGY CORPORATION | 2002-12-05 | — | — | US | disclosed |
| WO-2002075306-A1 | EPISOMAL NON-TRANSFORMING NUCLEIC ACID ELEMENTS IN FUNCTIONAL GENOMIC AND ANTIGENIC APPLICATIONS | LARGE SCALE BIOLOGY CORPORATION (US) | 2002-09-26 | — | — | WO | disclosed |
| US-4749647-A | Polymerization-induced separation assay using recognition pairs | GENETIC SYSTEMS CORPORATION (US) | 1988-06-07 | — | — | US | disclosed |